Search Results 761-770 of 13833 for Assay

  1. Kristina Kirschner, Ph.D., M.S. - Mayo Clinic Faculty Profiles

    This approach includes detailed mechanistic studies using biochemical and cell biological assays along with broader genome-wide investigations and ...

  2. Hematology - Clinical trials

    CfDNA Assay Prospective Observational Validation For Early Cancer Detection And Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  3. 'Clarity, confidence and hope': Comprehensive management of MS - Mayo Clinic

    That assay provides valuable information about disease activity, treatment response and long-term prognosis. "Our expertise allows us to carefully integrate ...

  4. Uterine microbe found to have disease-causing behavior in endometrial cancer - Mayo Clinic News Network

    "Through multiple lines of investigation, including invasion assays, microscopy, genomic and transcriptomic analysis, we verified that the microbe was ...

  5. A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma (SubQSA) - Mayo Clinic

    Serum free light chain (FLC) assay: Involved FLC assay ≥10 mg/dL (≥100 mg/L) and an abnormal serum FLC ratio (<0.26 or >1.65). Participants with relapsed ...

  6. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    A negative QuantiFERON® TB-Gold In-Tube test (or centrally reported equivalent assay) at screening; AND; A chest radiograph (views as per local guidelines) ...

  7. Ampullary Cancer Clinical Trials - Mayo Clinic Research

    GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study ...

  8. Obstetrics and Gynecology Clinical Trials - Medical Professionals

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  9. Publications - Vlad C. Vasile, M.D., Ph.D. - Mayo Clinic

    Method Validation of Dipeptidyl Peptidase 3 Assay. J Appl Lab Med. 2026 Mar ... Biological and analytical variability of a novel high-sensitivity cardiac troponin ...

  10. Mayo Clinic Minute: How precise diagnosis of lymphoma offers patients best treatment options

    And what we're doing is going through the most common types of lymphomas, and trying to build a series of assays that will answer several different diagnostic ...